← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Chemokine Pharmaceutical, Inc.
San Diego, CA
$2,643,976
Total funding
4
Grants
Funding over time
peak $1M · FY2005–07$2M$1.5M$1M$500K$0
'05
'06
'07
Funding mix
By agency
NIH$2,643,976 · 4
By mechanism
R43$2,643,976 · 4
Investigators at Chemokine Pharmaceutical, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
New Theraputics for Graft-Versus-Host Disease$387,982
R43 · FY2006 · AI
New Theraputics for Graft-Versus-Host Disease$387,982
R43 · FY2007 · AI
STRUCTURE-BASED DISCOVERY OF CD4-MHC CLASS II INHIBITORS$319,074
R43 · FY2006 · AI
DEVELOPMENT OF CD8-MHC CLASS I INHIBITORS$319,074
R43 · FY2005 · AI
DEVELOPMENT OF CD8-MHC CLASS I INHIBITORS$319,074
R43 · FY2006 · AI
STRUCTURE-BASED DISCOVERY OF CD4-MHC CLASS II INHIBITORS$319,074
R43 · FY2005 · AI
STRUCTURE-BASED DISCOVERY OF HIV-1 ENTRY INHIBITORS$299,026
R43 · FY2005 · AI
STRUCTURE-BASED DISCOVERY OF GP120-CD4 INHIBITORS$292,690
R43 · FY2004 · AI